JP4535234B2 - 腸管洗浄製剤 - Google Patents
腸管洗浄製剤 Download PDFInfo
- Publication number
- JP4535234B2 JP4535234B2 JP2003539642A JP2003539642A JP4535234B2 JP 4535234 B2 JP4535234 B2 JP 4535234B2 JP 2003539642 A JP2003539642 A JP 2003539642A JP 2003539642 A JP2003539642 A JP 2003539642A JP 4535234 B2 JP4535234 B2 JP 4535234B2
- Authority
- JP
- Japan
- Prior art keywords
- magnesium
- intestinal
- meq
- ions
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 58
- 230000000968 intestinal effect Effects 0.000 title claims description 65
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 claims abstract description 25
- 229910001425 magnesium ion Inorganic materials 0.000 claims abstract description 25
- 229920003169 water-soluble polymer Polymers 0.000 claims abstract description 24
- 239000003792 electrolyte Substances 0.000 claims abstract description 19
- 229920001223 polyethylene glycol Polymers 0.000 claims abstract description 19
- 239000002202 Polyethylene glycol Substances 0.000 claims abstract description 18
- 239000011777 magnesium Substances 0.000 claims abstract description 14
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims abstract description 13
- 229910052749 magnesium Inorganic materials 0.000 claims abstract description 13
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 claims abstract description 10
- 229910001414 potassium ion Inorganic materials 0.000 claims abstract description 9
- 229910001415 sodium ion Inorganic materials 0.000 claims abstract description 9
- NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 claims abstract description 4
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 claims abstract description 4
- 230000002262 irrigation Effects 0.000 claims description 34
- 238000003973 irrigation Methods 0.000 claims description 34
- 239000002518 antifoaming agent Substances 0.000 claims description 12
- 229940091250 magnesium supplement Drugs 0.000 claims description 12
- 235000002538 magnesium citrate Nutrition 0.000 claims description 8
- PLSARIKBYIPYPF-UHFFFAOYSA-H trimagnesium dicitrate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O PLSARIKBYIPYPF-UHFFFAOYSA-H 0.000 claims description 8
- 229960005336 magnesium citrate Drugs 0.000 claims description 7
- 239000004337 magnesium citrate Substances 0.000 claims description 7
- 239000000843 powder Substances 0.000 claims description 4
- 238000002052 colonoscopy Methods 0.000 abstract description 4
- 238000001356 surgical procedure Methods 0.000 abstract description 4
- 230000000112 colonic effect Effects 0.000 abstract description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 15
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 14
- 238000004140 cleaning Methods 0.000 description 14
- 229960003511 macrogol Drugs 0.000 description 14
- 239000000243 solution Substances 0.000 description 13
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 12
- 238000005187 foaming Methods 0.000 description 11
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- 239000012530 fluid Substances 0.000 description 10
- 210000001035 gastrointestinal tract Anatomy 0.000 description 10
- 150000002500 ions Chemical class 0.000 description 10
- 239000012085 test solution Substances 0.000 description 10
- 239000000203 mixture Substances 0.000 description 9
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 8
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 8
- 235000017557 sodium bicarbonate Nutrition 0.000 description 8
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 8
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 239000001103 potassium chloride Substances 0.000 description 6
- 235000011164 potassium chloride Nutrition 0.000 description 6
- 206010047700 Vomiting Diseases 0.000 description 5
- 238000009472 formulation Methods 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 description 4
- 229920001030 Polyethylene Glycol 4000 Polymers 0.000 description 4
- 230000013872 defecation Effects 0.000 description 4
- KVNZYYKJJVJHBV-UHFFFAOYSA-L magnesium;hydron;2-hydroxypropane-1,2,3-tricarboxylate;pentahydrate Chemical compound O.O.O.O.O.[Mg+2].OC(=O)CC(O)(C([O-])=O)CC([O-])=O KVNZYYKJJVJHBV-UHFFFAOYSA-L 0.000 description 4
- 230000008673 vomiting Effects 0.000 description 4
- 206010002091 Anaesthesia Diseases 0.000 description 3
- 230000037005 anaesthesia Effects 0.000 description 3
- 210000002429 large intestine Anatomy 0.000 description 3
- 229940085991 phosphate ion Drugs 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 229920002307 Dextran Polymers 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 229920000084 Gum arabic Polymers 0.000 description 2
- 229920001612 Hydroxyethyl starch Polymers 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 229920001100 Polydextrose Polymers 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 241000978776 Senegalia senegal Species 0.000 description 2
- 239000000205 acacia gum Substances 0.000 description 2
- 235000010489 acacia gum Nutrition 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 210000004534 cecum Anatomy 0.000 description 2
- 210000001072 colon Anatomy 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 210000003608 fece Anatomy 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 229940050526 hydroxyethylstarch Drugs 0.000 description 2
- 238000002350 laparotomy Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 235000010987 pectin Nutrition 0.000 description 2
- 239000001814 pectin Substances 0.000 description 2
- 229920001277 pectin Polymers 0.000 description 2
- 239000001259 polydextrose Substances 0.000 description 2
- 235000013856 polydextrose Nutrition 0.000 description 2
- 229940035035 polydextrose Drugs 0.000 description 2
- PJAHUDTUZRZBKM-UHFFFAOYSA-K potassium citrate monohydrate Chemical compound O.[K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O PJAHUDTUZRZBKM-UHFFFAOYSA-K 0.000 description 2
- 229940050931 potassium citrate monohydrate Drugs 0.000 description 2
- 210000000664 rectum Anatomy 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- 229960000999 sodium citrate dihydrate Drugs 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 239000008215 water for injection Substances 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 241000792859 Enema Species 0.000 description 1
- 239000004705 High-molecular-weight polyethylene Substances 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- WINXNKPZLFISPD-UHFFFAOYSA-M Saccharin sodium Chemical compound [Na+].C1=CC=C2C(=O)[N-]S(=O)(=O)C2=C1 WINXNKPZLFISPD-UHFFFAOYSA-M 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000005587 bubbling Effects 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 229960002086 dextran Drugs 0.000 description 1
- 230000000741 diarrhetic effect Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000007920 enema Substances 0.000 description 1
- 229940095399 enema Drugs 0.000 description 1
- 210000003722 extracellular fluid Anatomy 0.000 description 1
- 239000004503 fine granule Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 229940113601 irrigation solution Drugs 0.000 description 1
- 239000003621 irrigation water Substances 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229940057838 polyethylene glycol 4000 Drugs 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- 239000012487 rinsing solution Substances 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- ZSGPXUGYQIQEOF-UHFFFAOYSA-H trimagnesium;2-hydroxypropane-1,2,3-tricarboxylate;pentahydrate Chemical compound O.O.O.O.O.[Mg+2].[Mg+2].[Mg+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O ZSGPXUGYQIQEOF-UHFFFAOYSA-H 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Detergent Compositions (AREA)
Description
マクロゴール(登録商標)6000 29.5g、クエン酸水素マグネシウム5水和物18.9g、炭酸水素ナトリウム0.843g、無水硫酸ナトリウム1.17gおよび塩化カリウム0.198gを加えて全量を500mLとして本発明液を調製した。
また、マクロゴール(登録商標)4000 29.5g、塩化ナトリウム0.733g、塩化カリウム0.371g、無水硫酸ナトリウム2.84gおよび炭酸水素ナトリウム0.843gを秤量し、注射用水を加えて全量を500mLとして対照液を調製した。
以下の試験液を調製した。
試験液Aとして、マクロゴール(登録商標)4000 118g、塩化ナトリウム2.93g、塩化カリウム1.49g、無水硫酸ナトリウム11.4g、および炭酸水素ナトリウム3.37gを混合後、水を約1000mL加えて転倒混和して泡立ちを確認後、等張になるように水を加えて全量を2000mLとした。
マクロゴール(登録商標)4000 29.5g、クエン酸水素マグネシウム5水和物18.9g、炭酸水素ナトリウム0.843g、クエン酸ナトリウム2水和物0.913g、クエン酸カリウム1水和物0.211gを加えて全量を500mLとして本発明液を調製した。
また、マクロゴール(登録商標)4000 29.5g、塩化ナトリウム0.733g、塩化カリウム0.371g、無水硫酸ナトリウム2.84gおよび炭酸水素ナトリウム0.843gを秤量し、注射用水を加えて全量を500mLとして対照液を調製した。
マクロゴール(登録商標)6000 60g、無水クエン酸マグネシウム18.7g、炭酸水素ナトリウム1.79、クエン酸ナトリウム2水和物6.5gおよびクエン酸カリウム1水和物0.9gを秤量し、注射用水を加えて全量を1Lとして本発明の腸管洗浄液を調製した。対照液には市販の経口腸管洗浄製剤マグコロール(登録商標)P(堀井製薬社製)を用いた。
試験当日は絶食とし、朝8時より本発明の腸管洗浄液または対照の腸管洗浄液750mLを、250mL/15分の速度で45分をかけて服用し、服用開始から排便開始までの時間、および便の状態、水様便になるまでの時間を、最大6時間まで測定した。
ボランティア6名のうち3名は第1週に本発明の腸管洗浄液、翌週に対照の腸管洗浄液を服用し、残りの3名は、第1週に対照の腸管洗浄液、翌週に本発明の腸管洗浄液を服用した。
表1:本発明の腸管洗浄液服用後の排便状態
Claims (8)
- 水溶性高分子として平均分子量5000以上のポリエチレングリコールおよび電解質を含有する腸管洗浄製剤において、マグネシウムイオンをマグネシウムとして0.1〜3g/dL含有することを特徴とする腸管洗浄製剤。
- 電解質として、ナトリウムイオン30〜150mEq/L、カリウムイオン3〜20mEq/Lおよび重炭酸イオン10〜30mEq/Lを含有することを特徴とする請求項1に記載の腸管洗浄製剤。
- 水溶性高分子として、平均分子量7300〜9300のポリエチレングリコールを用いることを特徴とする請求項1に記載の腸管洗浄製剤。
- さらに消泡剤を含有することを特徴とする請求項1ないし3のいずれかに記載の腸管洗浄製剤。
- マグネシウムイオンをマグネシウムとして0.2〜1.6g/dL含有することを特徴とする請求項1ないし4のいずれかに記載の腸管洗浄製剤。
- マグネシウムイオンとして、クエン酸マグネシウムを含有することを特徴とする請求項5に記載の腸管洗浄製剤。
- 水溶性高分子として、平均分子量7300〜9300のポリエチレングリコール10〜160g/L、電解質として、ナトリウムイオン30〜150mEq/L、カリウムイオン3〜20mEq/L、重炭酸イオン10〜30mEq/L、マグネシウムイオンをマグネシウムとして0.1〜3g/dL含有することを特徴とする腸管洗浄製剤。
- 服用時に溶液製剤として使用される粉末製剤の形態にある請求項1ないし7のいずれかに記載の腸管洗浄製剤。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001330626 | 2001-10-29 | ||
JP2001330627 | 2001-10-29 | ||
PCT/JP2002/011188 WO2003037298A2 (en) | 2001-10-29 | 2002-10-29 | Bowel cleansing agent |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2005507407A JP2005507407A (ja) | 2005-03-17 |
JP4535234B2 true JP4535234B2 (ja) | 2010-09-01 |
Family
ID=26624158
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2003539642A Expired - Fee Related JP4535234B2 (ja) | 2001-10-29 | 2002-10-29 | 腸管洗浄製剤 |
Country Status (7)
Country | Link |
---|---|
US (1) | US20050003021A1 (ja) |
EP (1) | EP1443899B1 (ja) |
JP (1) | JP4535234B2 (ja) |
AT (1) | ATE477790T1 (ja) |
AU (1) | AU2002335900A1 (ja) |
DE (1) | DE60237384D1 (ja) |
WO (1) | WO2003037298A2 (ja) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6946149B2 (en) * | 2002-04-30 | 2005-09-20 | Braintree Laboratories, Inc. | Salt solution for colon cleansing |
GB0224909D0 (en) * | 2002-10-25 | 2002-12-04 | Norgine Europe Bv | Colon cleansing compositions |
JP2005187448A (ja) * | 2004-04-02 | 2005-07-14 | Ajinomoto Co Inc | 腸管洗浄用組成物 |
US7495063B2 (en) | 2006-02-03 | 2009-02-24 | Dow Global Technologies Inc. | Reduced oligomer concentration in high purity polyalkylene glycols |
AU2011101324B4 (en) * | 2009-07-17 | 2012-01-19 | Norgine Bv | Improvements in and relating to colon cleansing compositions |
GB0913295D0 (en) | 2009-07-30 | 2009-09-02 | Norgine Bv | Improvements in and relating to pharmaceutical compositions |
ES2409842T3 (es) * | 2009-11-02 | 2013-06-28 | Promefarm S.R.L. | Composiciones para la limpieza intestinal y uso de las mismas |
CA2825808C (en) | 2011-01-28 | 2020-09-01 | William A. Shaver | Method, composition and package for bowel cleansing |
PT2862566T (pt) * | 2011-01-31 | 2022-06-02 | Norgine Healthcare B V | Melhorias em, e relativas a, composições |
TWI535461B (zh) | 2011-03-11 | 2016-06-01 | 諾金私人有限公司 | 結腸清潔溶液、用於製備該溶液之組成物、包含該組成物或溶液之套組、與製備該溶液之方法 |
US9149493B2 (en) | 2011-11-28 | 2015-10-06 | Alfa Wassermann Spa | Compositions for bowel cleansing and use thereof |
IN2015DN01704A (ja) | 2012-09-11 | 2015-05-22 | Norgine Bv |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3121663A (en) * | 1956-02-09 | 1964-02-18 | Plough Lab Inc | Carbon dioxide releasing laxative suppository |
JPH04198126A (ja) * | 1990-11-28 | 1992-07-17 | Otsuka Pharmaceut Factory Inc | 腸管洗浄用液剤 |
JP3047143B2 (ja) * | 1992-04-24 | 2000-05-29 | 堀井薬品工業株式会社 | 腸管洗浄液用組成物及び腸管洗浄液 |
US5710183A (en) * | 1995-07-14 | 1998-01-20 | Halow; George M. | Laxative/antidiarrheal composition comprising polyethylene glycol and fiber bulking agent |
AUPN634595A0 (en) * | 1995-11-03 | 1995-11-30 | Borody, Thomas Julius | Improved method for colonic evacuation |
JP4092748B2 (ja) * | 1997-09-05 | 2008-05-28 | ニプロ株式会社 | 腸管洗浄液 |
US6268205B1 (en) * | 1998-05-04 | 2001-07-31 | Biomanagement Services, Inc. | Subsurface decontamination method |
FR2784897B1 (fr) * | 1998-10-27 | 2002-11-29 | Agronomique Inst Nat Rech | Utilisation d'un laxatif osmotique non fermente dans le traitement et la prevention des cancers colorectaux |
JP2001181181A (ja) * | 1999-12-24 | 2001-07-03 | Nof Corp | ポリエチレングリコールの保存方法 |
EP1337264B1 (en) * | 2000-10-13 | 2008-10-08 | E-Z-EM, Inc. | A nutritional dietary system, formulation, kit and method for use in preparing an individual for a predetermined activity |
US7291324B2 (en) * | 2002-10-22 | 2007-11-06 | Braintree Laboratories Inc. | Method of bowel cleansing |
-
2002
- 2002-10-29 US US10/493,991 patent/US20050003021A1/en not_active Abandoned
- 2002-10-29 DE DE60237384T patent/DE60237384D1/de not_active Expired - Lifetime
- 2002-10-29 AU AU2002335900A patent/AU2002335900A1/en not_active Abandoned
- 2002-10-29 AT AT02770290T patent/ATE477790T1/de not_active IP Right Cessation
- 2002-10-29 WO PCT/JP2002/011188 patent/WO2003037298A2/en active Application Filing
- 2002-10-29 JP JP2003539642A patent/JP4535234B2/ja not_active Expired - Fee Related
- 2002-10-29 EP EP02770290A patent/EP1443899B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US20050003021A1 (en) | 2005-01-06 |
EP1443899A2 (en) | 2004-08-11 |
JP2005507407A (ja) | 2005-03-17 |
EP1443899B1 (en) | 2010-08-18 |
WO2003037298A2 (en) | 2003-05-08 |
DE60237384D1 (de) | 2010-09-30 |
AU2002335900A1 (en) | 2003-05-12 |
WO2003037298A3 (en) | 2003-07-10 |
ATE477790T1 (de) | 2010-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2008001724A5 (ja) | ||
JP3255641B2 (ja) | 胃腸洗剤、若しくは緩下剤として使用する経口投与医薬組成物 | |
JP4535234B2 (ja) | 腸管洗浄製剤 | |
JP2509594B2 (ja) | 低ナトリウム緩下剤および洗浄剤処方 | |
RU2013138672A (ru) | Способ, композиция и набор для чистки кишечника | |
JP3047143B2 (ja) | 腸管洗浄液用組成物及び腸管洗浄液 | |
RU2009105770A (ru) | Сухая композиция для смешивания с водой (варианты), очистительный препарат и набор компонентов для очистки толстой кишки и способ очищения толстой кишки (варианты) | |
US9149493B2 (en) | Compositions for bowel cleansing and use thereof | |
ES2409842T3 (es) | Composiciones para la limpieza intestinal y uso de las mismas | |
KR101981069B1 (ko) | 장세척 조성물 | |
JP2721929B2 (ja) | 腸管洗浄用組成物 | |
US20150320793A1 (en) | Compositions and Solutions for Colon Cleansing | |
JP2004323479A (ja) | 便秘用緩下剤 | |
JP2004323456A (ja) | 腸管洗浄製剤 | |
JP2002265372A (ja) | 腸管洗浄製剤 | |
JP2711409B2 (ja) | 腸管洗浄用組成物 | |
JP2527611B2 (ja) | 腸管洗浄用組成物 | |
JPH0215030A (ja) | トリアムテレン医薬溶液 | |
KR20230140488A (ko) | 장 정결용 조성물 | |
BR112020004453A2 (pt) | composição para suplementação de cálcio | |
KR20220122534A (ko) | 장세척을 위한 조성물 | |
Schiller | Colon preparation: Is less more? | |
US20160271120A1 (en) | Pharmaceutical composition for cleansing of the gastrointestinal tract | |
JP2005097270A (ja) | 嚥下容易な腸管洗浄用製剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A712 Effective date: 20050509 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20050915 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20090701 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20090827 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20100526 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130625 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20100608 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130625 Year of fee payment: 3 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130625 Year of fee payment: 3 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |